Literature DB >> 12726927

Adenosine deaminase and xanthine oxidase activities in bladder washing fluid from patients with bladder cancer: a preliminary study.

Mukaddes Güleç1, Haluk Akin, Hüseyin Yüce H, Ertürk Ergin, Halit Elyas, Orhan Yalçin, Omer Akyol.   

Abstract

Activities of adenosine deaminase (AD), and xanthine oxidase (XO) enzymes were measured in bladder washing fluid (BWF) from 37 patients with bladder cancer. The patients were divided into several groups according to their sex; pattern, number, and depth of the tumors; and tumor grade. There was a statistically significant difference in XO activities between the patients having no tumor and papillary tumor (p < 0.002). The differences in XO values between the patients having no tumor and single tumor; and with no tumor and multiple tumors were statistically significant (p < 0.012, p < 0.016 respectively). XO activities were increased in patients with both papillary and multiple tumors compared to tumor-free group. Regarding to the depth of tumors, only the differences in XO values between the patients having no tumor and superficial tumor was statistically significant (p < 0.037). XO values of patients in grade1 were higher than the patients having no tumor (p < 0.010). AD activities in patients with multiple and invasive tumor were increased compared to patients with single and superficial tumor. AD values in grade 3 were lower than grade 2. However, we did not find any statistically significant differences in AD activities in all groups. As a conclusion, increased XO activity in BWF might be a potentially important finding as an additional diagnostic biochemical tool for bladder cancer. But we could not say this for AD activity. Further investigations in a larger cohort of patients with bladder cancer are needed to enlighten the possible diagnostic role of XO and AD in BWF.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12726927     DOI: 10.1016/s0009-9120(02)00452-6

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  6 in total

1.  Syzygium cumini is more effective in preventing the increase of erythrocytic ADA activity than phenolic compounds under hyperglycemic conditions in vitro.

Authors:  Karine S De Bona; Gabriela Bonfanti; Paula E R Bitencourt; Lariane O Cargnelutti; Priscila S da Silva; Thainan P da Silva; Régis A Zanette; Aline S Pigatto; Maria B Moretto
Journal:  J Physiol Biochem       Date:  2014-01-10       Impact factor: 4.158

2.  Serum adenosine deaminase, catalase, and carbonic anhydrase activities in patients with renal cell carcinoma.

Authors:  Necip Pirinççi; Tacettin Yekta Kaya; Mehmet Kaba; Tunç Ozan; İlhan Geçit; Hüseyin Özveren; Hüseyin Eren; Kadir Ceylan
Journal:  Redox Rep       Date:  2016-07-14       Impact factor: 4.412

3.  Vitamin E protects against oxidative damage caused by formaldehyde in the liver and plasma of rats.

Authors:  Mukaddes Gulec; Ahmet Gurel; Ferah Armutcu
Journal:  Mol Cell Biochem       Date:  2006-08-26       Impact factor: 3.396

4.  Serum adenosine deaminase, catalase and carbonic anhydrase activities in patients with bladder cancer.

Authors:  Necip Pirinççi; Ilhan Geçit; Mustafa Güneş; Mehmet Bilgehan Yüksel; Mehmet Kaba; Serhat Tanık; Halit Demir; Mehmet Aslan
Journal:  Clinics (Sao Paulo)       Date:  2012-12       Impact factor: 2.365

5.  Levels of certain tumor markers as differential factors between bilharzial and non-biharzial bladder cancer among Egyptian patients.

Authors:  Nadia S Metwally; Sanaa A Ali; Azza M Mohamed; Hussein M Khaled; Samia A Ahmed
Journal:  Cancer Cell Int       Date:  2011-04-07       Impact factor: 5.722

6.  New therapeutic targets in the management of urothelial carcinoma of the bladder.

Authors:  Einar F Sverrisson; Patrick N Espiritu; Philippe E Spiess
Journal:  Res Rep Urol       Date:  2013-03-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.